THIS ANNOUNCEMENT (AND THE INFORMATION CONTAINED HEREIN) IS NOT FOR RELEASE, PUBLICATION, DISTRIBUTION OR FORWARDING, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.
FOR IMMEDIATE RELEASE
Hammerson plc (the "Company")
Final 2021 Dividend and Enhanced Scrip Dividend Alternative
5 May 2022
Further to the announcement of the Final 2021 Dividend and the Enhanced Scrip Dividend Alternative on Friday, 4 March 2022, the Board of Hammerson plc announces that valid elections to participate in the Enhanced Scrip Dividend Alternative were received from Shareholders holding 3,716,406,719 Shares. Accordingly, the number of New Shares to be issued under the Enhanced Scrip Dividend Alternative is 194,637,920.
Therefore, applications have been submitted for 194,637,920 New Shares to be admitted to trading on the London Stock Exchange, the secondary listing segment of the Official List of the Irish Stock Exchange plc, trading as Euronext Dublin, and the Johannesburg Stock Exchange, which will bring the total number of issued 5 pence ordinary shares in the Company to 4,614,095,081.
The New Shares are expected to be issued and admitted to trading on the Main Market of the London Stock Exchange, Euronext Dublin and the Johannesburg Stock Exchange on Tuesday, 10 May 2022. A further announcement will be released to confirm when those New Shares have been issued and admitted to trading on the respective stock exchanges.
Unless otherwise stated, capitalised terms in this announcement shall have the meanings given to them in the Circular dated Wednesday, 23 March 2022 in connection with the Final 2021 Dividend and Enhanced Scrip Dividend Alternative which can be found at: https://www.hammerson.com/investors/dividend/scrip-dividend
Enquiries
Josh Warren, Director of Strategy and Investor Relations
Tel: +44 20 7887 1053
josh.warren@hammerson.com
The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange and on Euronext Dublin.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
